pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4699 |
Genomic Coordinates | chr12: 81158388 - 81158461 |
Description | Homo sapiens miR-4699 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4699-3p | |||||||||||||||
Sequence | 46| AAUUUACUCUGCAAUCUUCUCC |67 | |||||||||||||||
Evidence | Experimental | |||||||||||||||
Experiments | Illumina | DRVs in miRNA |
|
|||||||||||||
SNPs in miRNA |
|
|||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | EDEM3 | ||||||||||||||||||||
Synonyms | C1orf22 | ||||||||||||||||||||
Description | ER degradation enhancing alpha-mannosidase like protein 3 | ||||||||||||||||||||
Transcript | NM_025191 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on EDEM3 | |||||||||||||||||||||
3'UTR of EDEM3 (miRNA target sites are highlighted) |
>EDEM3|NM_025191|3'UTR 1 CTTGCTAAACAATCTGTTGGTAGGTATTTAAAAAGAAAAGGTAAACTGTGTGTGGTTAATAGACATCCTAATACTAAGCA 81 GGCTTTCTAATGGGAGGCTTTAAGTATGGTGATGAACAACCACGTTCTGACTGGCGTAGTTATCGTAGGAATCTGGAGCA 161 TGCTGTGTTAGAATTGACCTTGTTTAAAACTGTCCCATCAAAAATGGAAATCCACAGTTCCCCCTTCAAATGCAGCACTG 241 CACCACCCTGCAACACCTCAGGCCAGGGAAAGATTACTGAGCATTCCTGCGAACCAGATTTCTGTTGTCTCTGGATAGAC 321 AAGAAACAAAATTCATTTAGTAGTGGAGTGGGGAATAGGAGTTTGGATAGCCTTCTAATTAAAGGAAGCTCGCCTTTCTT 401 GGTTTTGGGGGTTAGAGGCTCTTTTGGGAAGATGCATCCGAGTATTGTGGCATTCTGATTATGCTGCCTTCACAAAACAC 481 TCTAAGTGACCTAAGTGGTTATGAAGCAAATGCATTTATGGTGAAAACAGTCTTTGCTCATTGCTTTCTCTTGTTTCATT 561 TAGTGACAAATGATCAAGATGACTTGATTTTTTTTCCTTCTTAACAATGTCTTTTTTATTTAAACCAAAGGTGAAGCCAG 641 TGTACTTTCTCAGTGAGTTCTCTGCATAAAGACTAATCAGTGGGACCAGGTAAAAAGGTCATATAATACATTGTGGAGAT 721 TGCTTACTTAATACTTCTGAAAAATGGAGTAAGGGAGAAACTGTAATGTTGCAATATGAACCTCCCATTGGGCCTTCCAT 801 AGGGAAAGCTGTGACTACTCTGAAATGGAACCTAGCATTATATCCTTGTAGGGTAGATTATAAATCATTTCCAGTTCATT 881 TCTCTTAGAGGTGATTACCTCTAGCCATCAGCCTTACTCCATCCCATGTTTGGTATGCAATTTGAGCCACAAGGCTCGTA 961 TCGCCAACAGCTATATACATTTTGTTCCATTTTTCTGTCTTACAGAGCCATGATAGAACTGTGGTTAGTGAGTTAAAATT 1041 CCTGGAGTAACTACTGTTTTTCTCCTTTGAAACTTAGGTTTCTAAAGTTGCACCTAAGGAATCTGTCACATTTTCTGTTG 1121 AATCATGGTTTTTGTTTTTGTTTTTAACAGATATTCCTTCTGATACGGACTTGAAAATTAGTGTATGGTGACCTGTGTTT 1201 AAAAAAAAAAGTACAATACAACTACATATAGCTATATAGCTTAATGAGACTTCCACCCCCCCCCTTTTTTTTTTTGGTTT 1281 GTTGTTGTTGTAGTAGTCTGGTGCTGGCCACATTTAAGTCTTAAAAATTTTTAAATTTTGTTGTTGATGTTTGTAGACAG 1361 CCCTGTTGTTGAAATCATGGCTTTATTCATTTTATTTATTTTTTAAACTTGCCTGAATTTGTTCTAAAGGAATATTTAAG 1441 AGACATAATTTTCTTCTCTTTACCATAACATTACACAAAACTTTTTCCTAAAACACGGTTGTGAGGTACTGATGAGGTGT 1521 AAGTGGAGCTGTTAAAAACAGCAGTGCTGTATTGCAGTTATGTATATTCGTGTACAGTATGTTTAGATCCCAGGTAAACA 1601 TATTCTTTTCTGAGAGGATAAATACCTGCATTCAGATATTCCAGGTAAATATAATTGAGTCAGGGAGTAGTAAATCTGAT 1681 GGAGAATTCACTTTGGGGAGGGGAAAAAGAATAGTATGCAAGACCCTTATTGGCTTTTAATTATACCTGAAACCAAAATG 1761 GATATTTTTAGTCTCTCTGCATGTGAGATTTGGTGTAACAAGATAGAACTATAATATATACAGTATATGGAAGGATAGAT 1841 ATAGTGCTTTGTTCATTTTAATTGCAAAGCTGCCAAAATAGTTGAAGCTTAATTACTTGACTTGCCTTGATTTATAGGAC 1921 TGGGGCTTGGAGAAAATGAGCAGATGTTCCTCTAAGACATCGATTACAGAAGCCTTATATACATGGATTTGATTTTGTAT 2001 TTGTAGCTGAAAGTCACTGTTGTCTAAAACTAACTTTTCTAAGTTATCAAAACAACCTAATTTCTTTTCCAACAAGGAGA 2081 ACTTAATGGCATGAAGGATTGTGTGACACATTGGAAAAGCCAGCTTACTGCCACTCTCTTCCTTTGGCCATTAGAGGGAG 2161 GTGTTGCCTTTCATTGACGCTTAGAAGCAAATTGTTCACTTGTTAAGAAAAGTAAATCCTTAAAAAAAGAAAAGGAAAAA 2241 ATTTAACCAATTTTTCTTAATACCCAGAAGGAATTATACTCAATATTTCCCTAGTTAAGAAAAGAGGAGATAATGTTCGT 2321 CTAAAAAACTCCAACGTTGTAATTACAACTCTACATTCATTTACTTACTTGACATACTGCCACAAAGTAGTTTTTGAGTT 2401 CATTAAAAATTCCAAAGGCATTAGTTGTTTTTTTTTTTTTTAGTGTTTTGTTTTTTAGTTAACTTTTATAGACATTTTAG 2481 TAACTTGCTAAAGATTCAGGGGATTCTATGAAACCCCGAATTTAGAAACATCTGGTCTACCTCAGTTAAATGTTGACTGC 2561 TTAGAAATATAGCTGAAGTGATCACCACAGCCATAAAATTGTTTAAGAAAGATTTATATAATGTTTACAAATCTGGAATC 2641 AAGGATTTTAGCTGAAATCCTTTAAGAGATATTAGAGCAAGTATTTAATTCAGGTATTTTCAAGTTTTAAAACTTAACCT 2721 GTTTACCTACTAAAAATAAAATAGCTAGTTTTTTTCTGCATATAAAAGTTCATTGAAATGATATGCCCTTATTTGCAATA 2801 CTTTTCCCATAAAGTTTTAAGTGTGAAAGAATTGTAATTTACTAGATATGTTTGGTATGGGATATTTTGTTAGGCAAGTT 2881 TTCTTTTTTCTTCTTAAATTGCAATAGGCTTCCAAAAAGAGTATAATTGTTTCAGAACAAATTAACTCTTGGCATTATAC 2961 GTCTCCCTTTTTCTTTACAGTATTAGTAAAAAGAAAAATTGTACACTTTCTGATTTTAACTTCACTAATGTAATTACTCT 3041 CTCAAGAAGCTTTTAAAATTTAAATTACCATCACACAACCTTTTTTATAGTAAAGCCAACATTTGTTCTCTCACCAAACC 3121 CCATGCCAAATTCATCATGAAGAAAGCTCAGCATAAGTAATTCAAATACTGCTTATAATTTTAGAGGGGGGTAGAATTTA 3201 GTAAATATTCCAGCCGGTCGTTTTATGCACAAGGCTTCAGTCAGAACATAGAAAAAAAAAACATTCTGTGAATGAAATAT 3281 TGTATGTTCAGATTTTATAAAAGACATTTTTAAAAGCCCAATTTACAGCCGTATATTTTCTTATGATGTAATTTATGAAA 3361 AAGATGTCTGTACTAACAGGTGCTGTAACACTACTGTTGTTGGATTTTATTGTTTGGTGATAAATGTATACAATATTTCT 3441 AAGGGAAACTATGTACTGTGATGTAAAAGTCTGGGCAAAATGTATATAATCCTGTATATAATTATGTATTTGATTATAAT 3521 TACTGATTGTAAAGATTTAATAAAATATGTAAATATTCCAGTTTAGTTTTAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 3601 AAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545215. RNA binding protein: AGO4. Condition:Control
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | hESCs (WA-09) | ||||||
Disease | 80267.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine
... - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al. - Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 80267.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065668. RNA binding protein: AGO1. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
Experimental Support 4 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HCT116 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177619. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_9
PAR-CLIP data was present in ERX177632. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_4_10
PAR-CLIP data was present in ERX177608. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_2_10
PAR-CLIP data was present in ERX177611. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_1
PAR-CLIP data was present in ERX177615. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_5
PAR-CLIP data was present in ERX177620. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_3_10
PAR-CLIP data was present in ERX177599. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_1
PAR-CLIP data was present in ERX177603. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_5
PAR-CLIP data was present in ERX177623. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_1
PAR-CLIP data was present in ERX177627. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_5
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
Experimental Support 5 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Prostate Tissue |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760639. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP-MDV_A
PAR-CLIP data was present in SRX1760641. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP-MDV_B
PAR-CLIP data was present in SRX1760583. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP_A
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
CLIP-seq Support 1 for dataset GSM4903825 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / PID14_NS |
Location of target site | NM_025191 | 3UTR | AUUCUUUUCUGAGAGGAUAAAUACCUGCAUUCAGAUAUUCCAGGUAAAUAUAAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161237 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903826 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / PID21_NS |
Location of target site | NM_025191 | 3UTR | AUUCCAGGUAAAUAUAAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161237 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_025191 | 3UTR | UGUAUUGCAGUUAUGUAUAUUCGUGUACAGUAUGUUUAGAUCCCAGGUAAACAUAUUCUUUUCUGAGAGGAUAAAUACCUGCAUUCAGAUAUUCCAGGUAAAUAUAAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_025191 | 3UTR | UCUCACCAAACCCCAUGCCAAAUUCAUCAUGAAGAAAGCUCAGCAUAAGUAAUUCAAAUACUGCUUAUAAUUUUAGAGGGGGGUAGAAUUUAGUAAAUAUUCCAGCCGGUCGUUUUAUGCACAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_025191 | 3UTR | GUACAGUAUGUUUAGAUCCCAGGUAAACAUAUUCUUUUCUGAGAGGAUAAAUACCUGCAUUCAGAUAUUCCAGGUAAAUAUAAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_025191 | 3UTR | AAGAAAGCUCAGCAUAAGUAAUUCAAAUACUGCUUAUAAUUUUAGAGGGGGGUAGAAUUUAGUAAAUAUUCCAGCCGGUCGUUUUAUGCACAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_025191 | 3UTR | UUCGUGUACAGUAUGUUUAGAUCCCAGGUAAACAUAUUCUUUUCUGAGAGGAUAAAUACCUGCAUUCAGAUAUUCCAGGUAAAUAUAAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_025191 | 3UTR | CACCAAACCCCAUGCCAAAUUCAUCAUGAAGAAAGCUCAGCAUAAGUAAUUCAAAUACUGCUUAUAAUUUUAGAGGGGGGUAGAAUUUAGUAAAUAUUCCAGCCGGUCGUUUUAUGCACAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 9 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_025191 | 3UTR | AUGUUUAGAUCCCAGGUAAACAUAUUCUUUUCUGAGAGGAUAAAUACCUGCAUUCAGAUAUUCCAGGUAAAUAUAAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 10 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_025191 | 3UTR | CCAAACCCCAUGCCAAAUUCAUCAUGAAGAAAGCUCAGCAUAAGUAAUUCAAAUACUGCUUAUAAUUUUAGAGGGGGGUAGAAUUUAGUAAAUAUUCCAGCCGGUCGUUUUAUGCACAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 11 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_025191 | 3UTR | CUGCAUUCAGAUAUUCCAGGUAAAUAUAAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 12 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_025191 | 3UTR | ACCCCAUGCCAAAUUCAUCAUGAAGAAAGCUCAGCAUAAGUAAUUCAAAUACUGCUUAUAAUUUUAGAGGGGGGUAGAAUUUAGUAAAUAUUCCAGCCGGUCGUUUUAUGCACAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 13 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_025191 | 3UTR | UUCGUGUACAGUAUGUUUAGAUCCCAGGUAAACAUAUUCUUUUCUGAGAGGAUAAAUACCUGCAUUCAGAUAUUCCAGGUAAAUAUAAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 14 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_025191 | 3UTR | CAUGCCAAAUUCAUCAUGAAGAAAGCUCAGCAUAAGUAAUUCAAAUACUGCUUAUAAUUUUAGAGGGGGGUAGAAUUUAGUAAAUAUUCCAGCCGGUCGUUUUAUGCACAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 15 for dataset GSM545215 | |
---|---|
Method / RBP | PAR-CLIP / AGO4 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000318130.8 | 3UTR | UUUAGAGGGGGGUAGAAUUUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 16 for dataset SRR359787 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | hESCs (WA-09) / 4-thiouridine, RNase T1 |
Location of target site | ENST00000318130.8 | 3UTR | UUUUAGAGGGGGGUAGAAUUUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22012620 / SRX103431 |
CLIP-seq Viewer | Link |
CLIP-seq Support 17 for dataset GSM1065668 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_7 |
Location of target site | ENST00000318130.8 | 3UTR | AUUUUAGAGGGGGGUAGAAUUUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
88 hsa-miR-4699-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT056239 | RAB18 | RAB18, member RAS oncogene family | 2 | 2 | ||||||||
MIRT080536 | PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 2 | 2 | ||||||||
MIRT095600 | NR3C1 | nuclear receptor subfamily 3 group C member 1 | 2 | 2 | ||||||||
MIRT128911 | KMT2A | lysine methyltransferase 2A | 2 | 2 | ||||||||
MIRT161904 | FXR1 | FMR1 autosomal homolog 1 | 2 | 4 | ||||||||
MIRT177614 | UBE2D1 | ubiquitin conjugating enzyme E2 D1 | 2 | 4 | ||||||||
MIRT231364 | EDEM3 | ER degradation enhancing alpha-mannosidase like protein 3 | 2 | 6 | ||||||||
MIRT285164 | SERBP1 | SERPINE1 mRNA binding protein 1 | 2 | 2 | ||||||||
MIRT307337 | SEC22C | SEC22 homolog C, vesicle trafficking protein | 2 | 2 | ||||||||
MIRT317083 | DEK | DEK proto-oncogene | 2 | 2 | ||||||||
MIRT347692 | LSM14A | LSM14A, mRNA processing body assembly factor | 2 | 2 | ||||||||
MIRT358438 | STC2 | stanniocalcin 2 | 2 | 2 | ||||||||
MIRT362592 | PURB | purine rich element binding protein B | 2 | 4 | ||||||||
MIRT441441 | HAVCR1 | hepatitis A virus cellular receptor 1 | 2 | 2 | ||||||||
MIRT445264 | LOH12CR2 | loss of heterozygosity, 12, chromosomal region 2 (non-protein coding) | 2 | 4 | ||||||||
MIRT447097 | SNRPD1 | small nuclear ribonucleoprotein D1 polypeptide | 2 | 2 | ||||||||
MIRT449013 | ANKRD17 | ankyrin repeat domain 17 | 2 | 2 | ||||||||
MIRT450358 | SETD9 | SET domain containing 9 | 2 | 2 | ||||||||
MIRT454976 | MYC | MYC proto-oncogene, bHLH transcription factor | 2 | 2 | ||||||||
MIRT461922 | NECAB3 | N-terminal EF-hand calcium binding protein 3 | 2 | 2 | ||||||||
MIRT465191 | TRPS1 | transcriptional repressor GATA binding 1 | 2 | 2 | ||||||||
MIRT467685 | SLC38A2 | solute carrier family 38 member 2 | 2 | 4 | ||||||||
MIRT468003 | SKI | SKI proto-oncogene | 2 | 2 | ||||||||
MIRT473127 | MLLT10 | MLLT10, histone lysine methyltransferase DOT1L cofactor | 2 | 2 | ||||||||
MIRT476370 | GIGYF1 | GRB10 interacting GYF protein 1 | 2 | 2 | ||||||||
MIRT477067 | FAM208B | family with sequence similarity 208 member B | 2 | 4 | ||||||||
MIRT479950 | CBX4 | chromobox 4 | 2 | 4 | ||||||||
MIRT481092 | B3GNT2 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | 2 | 2 | ||||||||
MIRT481932 | ANKRD11 | ankyrin repeat domain 11 | 2 | 12 | ||||||||
MIRT482239 | AHCY | adenosylhomocysteinase | 2 | 2 | ||||||||
MIRT485804 | ARPP19 | cAMP regulated phosphoprotein 19 | 2 | 2 | ||||||||
MIRT492026 | TWF1 | twinfilin actin binding protein 1 | 2 | 2 | ||||||||
MIRT494389 | CALM3 | calmodulin 3 | 2 | 2 | ||||||||
MIRT504115 | GPR158 | G protein-coupled receptor 158 | 2 | 2 | ||||||||
MIRT506346 | NUP54 | nucleoporin 54 | 2 | 4 | ||||||||
MIRT510081 | PPWD1 | peptidylprolyl isomerase domain and WD repeat containing 1 | 2 | 4 | ||||||||
MIRT521019 | SLC8A1 | solute carrier family 8 member A1 | 2 | 2 | ||||||||
MIRT524709 | BTBD3 | BTB domain containing 3 | 2 | 2 | ||||||||
MIRT524989 | AGO2 | argonaute 2, RISC catalytic component | 2 | 6 | ||||||||
MIRT525003 | ACVR1B | activin A receptor type 1B | 2 | 2 | ||||||||
MIRT528064 | OLAH | oleoyl-ACP hydrolase | 2 | 2 | ||||||||
MIRT528865 | C1orf147 | chromosome 1 open reading frame 147 | 2 | 2 | ||||||||
MIRT532182 | DOCK7 | dedicator of cytokinesis 7 | 2 | 2 | ||||||||
MIRT533592 | TOB1 | transducer of ERBB2, 1 | 2 | 6 | ||||||||
MIRT538835 | C16orf70 | chromosome 16 open reading frame 70 | 2 | 2 | ||||||||
MIRT539488 | ACVR1C | activin A receptor type 1C | 2 | 2 | ||||||||
MIRT539542 | ABCD2 | ATP binding cassette subfamily D member 2 | 2 | 2 | ||||||||
MIRT542123 | VENTX | VENT homeobox | 2 | 2 | ||||||||
MIRT542993 | ELOVL5 | ELOVL fatty acid elongase 5 | 2 | 2 | ||||||||
MIRT543067 | ATXN7L3B | ataxin 7 like 3B | 2 | 2 | ||||||||
MIRT543370 | CYB5B | cytochrome b5 type B | 2 | 2 | ||||||||
MIRT545080 | TSEN34 | tRNA splicing endonuclease subunit 34 | 2 | 2 | ||||||||
MIRT545258 | TRIM36 | tripartite motif containing 36 | 2 | 4 | ||||||||
MIRT549144 | BRIX1 | BRX1, biogenesis of ribosomes | 2 | 2 | ||||||||
MIRT549403 | AKAP1 | A-kinase anchoring protein 1 | 2 | 2 | ||||||||
MIRT552143 | MRPL34 | mitochondrial ribosomal protein L34 | 2 | 2 | ||||||||
MIRT554781 | RHEBP1 | RHEB pseudogene 1 | 2 | 4 | ||||||||
MIRT555991 | NFYB | nuclear transcription factor Y subunit beta | 2 | 2 | ||||||||
MIRT556425 | LONRF3 | LON peptidase N-terminal domain and ring finger 3 | 2 | 2 | ||||||||
MIRT558325 | DNAJC28 | DnaJ heat shock protein family (Hsp40) member C28 | 2 | 4 | ||||||||
MIRT561357 | YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta | 2 | 2 | ||||||||
MIRT562240 | HMGB1 | high mobility group box 1 | 2 | 2 | ||||||||
MIRT562269 | GOLT1B | golgi transport 1B | 2 | 2 | ||||||||
MIRT564020 | FAM103A1 | family with sequence similarity 103 member A1 | 2 | 2 | ||||||||
MIRT564832 | ZBTB16 | zinc finger and BTB domain containing 16 | 2 | 2 | ||||||||
MIRT565350 | TMED2 | transmembrane p24 trafficking protein 2 | 2 | 2 | ||||||||
MIRT565678 | SET | SET nuclear proto-oncogene | 2 | 2 | ||||||||
MIRT576547 | Txlna | taxilin alpha | 2 | 2 | ||||||||
MIRT609358 | ZNF664 | zinc finger protein 664 | 2 | 2 | ||||||||
MIRT610646 | CTGF | connective tissue growth factor | 2 | 2 | ||||||||
MIRT624681 | ARAP2 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 | 2 | 2 | ||||||||
MIRT637118 | AGTPBP1 | ATP/GTP binding protein 1 | 2 | 2 | ||||||||
MIRT639955 | PRRC2B | proline rich coiled-coil 2B | 2 | 2 | ||||||||
MIRT644051 | WWC2 | WW and C2 domain containing 2 | 2 | 2 | ||||||||
MIRT650463 | SLC35B1 | solute carrier family 35 member B1 | 2 | 2 | ||||||||
MIRT651094 | ZNF516 | zinc finger protein 516 | 2 | 2 | ||||||||
MIRT655268 | PER2 | period circadian clock 2 | 2 | 2 | ||||||||
MIRT657450 | HEYL | hes related family bHLH transcription factor with YRPW motif-like | 2 | 2 | ||||||||
MIRT692248 | POLR3F | RNA polymerase III subunit F | 2 | 2 | ||||||||
MIRT695239 | PBK | PDZ binding kinase | 2 | 2 | ||||||||
MIRT696024 | NDUFS3 | NADH:ubiquinone oxidoreductase core subunit S3 | 2 | 2 | ||||||||
MIRT698486 | TIAL1 | TIA1 cytotoxic granule associated RNA binding protein like 1 | 2 | 2 | ||||||||
MIRT700581 | PRSS22 | protease, serine 22 | 2 | 2 | ||||||||
MIRT704540 | CNEP1R1 | CTD nuclear envelope phosphatase 1 regulatory subunit 1 | 2 | 2 | ||||||||
MIRT704723 | CEP135 | centrosomal protein 135 | 2 | 2 | ||||||||
MIRT705194 | BTG1 | BTG anti-proliferation factor 1 | 2 | 2 | ||||||||
MIRT710286 | CSNK1G3 | casein kinase 1 gamma 3 | 2 | 2 | ||||||||
MIRT719623 | TUBGCP3 | tubulin gamma complex associated protein 3 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|